Patents by Inventor Phillip E. Schoenwetter

Phillip E. Schoenwetter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200046677
    Abstract: A pet hormone loss supplement composition to mitigate sex hormone loss of mammal pets that have been spayed or neutered. This proprietary formulation is comprised of a specific combination of well-known supplements or food that are generally regarded as safe (GRAS) and serendipitously share either phyto estrogen or phyto androgen properties of sufficient magnitude so as to be considered either a Selective Estrogen Receptor Modulator (SERM) or Selective Androgen Receptor Modulator (SARM) activity. These individual supplements of SERM and SARM properties (a novel and unique combination to maximize the number of hormone receptor site activation) provide a similar and sufficient array of sex hormone mimic activity so as to constitute a functional sex hormone supplement; helping to blunt or eliminate many hormone deficiency effects resulting from spaying or neutering and thus improve health span and possibly life span by more nearly replicating a natural hormone milieu.
    Type: Application
    Filed: October 22, 2019
    Publication date: February 13, 2020
    Inventors: Phillip E. Schoenwetter, Robin Coon
  • Publication number: 20160350510
    Abstract: Preventive urgent healthcare services utilizing web-based resources for medical approval and particularly, a preemptive medical kit prescribed in advance of likely common events during travel in North America and the Northern Hemisphere to be treated with a combination of over-the-counter and prescribed medications.
    Type: Application
    Filed: May 26, 2016
    Publication date: December 1, 2016
    Inventor: Phillip E. Schoenwetter
  • Publication number: 20150147389
    Abstract: An antioxidant composition comprises one or more amino acids; a genistein alternative selected from the group consisting of genistein, aglycon genistine, hormone receptive modulators, phosphordiesterase (PDE) inhibitors of types 1, 2, 3 and 4, anti-neoplastic tyrosine kinase inhibitors, and combinations thereof; and an icariin alternative selected from the group consisting of icarosides 1 or 2, PDE-4 inhibitors, PDE-5 inhibitors, derivatives of the epimedium species including icarrocides I and II, and combinations thereof.
    Type: Application
    Filed: November 21, 2014
    Publication date: May 28, 2015
    Inventor: Phillip E. Schoenwetter
  • Publication number: 20090176871
    Abstract: The novel applicability and methods of use of soy germ extracted isoflavones for the treatment of sex hormone loss due to spaying, neutering and aging in domestic pets as well as service and guide animals.
    Type: Application
    Filed: January 7, 2009
    Publication date: July 9, 2009
    Inventor: Phillip E. Schoenwetter